马斯科尼在COPD发展中的保护作用
Tiantian Feng1, Xiaolong Guo1, Wei Chen2
1School of Public Health, Centre for Evidence-Based Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Frontiers in immunology
|March 4, 2025
概括
香是一种香成分,在慢性阻塞性肺病 (COPD) 的小鼠模型中改善了肺功能. 它通过调节细胞因子表达来减少炎症,特别是增加抗炎性IL-38水平.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 香是一种香成分,具有抗炎性质.
- 它对COPD等炎症性肺部疾病的治疗潜力尚未得到充分研究.
- 这项研究探讨了Muscone在COPD小鼠模型中的保护作用.
研究的目的:
- 在慢性阻塞性肺病 (COPD) 的小鼠模型中研究Muscone的治疗潜力.
- 评估Muscone对肺功能,炎症和COPD小鼠相关细胞因子表达的影响.
主要方法:
- 一个COPD小鼠模型是由香烟烟雾和LPS暴露引起的.
- 小鼠接受了德克萨梅他或不同剂量的Muscone治疗.
- 评估了肺功能,组织病理,血清细胞因子水平 (IL-38,IL-1β,IL-17,TGF-β,IFN-γ) 和肺组织蛋白质表达 (CXCR3,IFN-γ,IL-17A,RORγt).
主要成果:
- 在COPD小鼠中,肌肉治疗改善了体重和肺功能.
- 马斯科纳的使用上调抗炎细胞因子 (包括IL-38) 和下调促炎细胞因子.
- 马斯科内抑制了肺组织中CXCR3,IFN-γ,IL-17A和RORγt的表达.
结论:
- 马斯科尼在COPD小鼠模型中显示出保护作用,改善了肺功能.
- 治疗机制可能涉及调节细胞因子表达,可能上调IL-38.
- 需要进一步的研究来阐明IL-38.8的确切机制和作用.
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K